AZD-3783

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

AZD-3783, also known as AZ12320927, is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder and anxiety disorders. It was being developed by AstraZeneca. The drug reached phase 1 clinical trials prior to the discontinuation of its development. It was discontinued following unexpected neurotoxicity findings in animals.

AZD-3783, also known as AZ12320927, is a serotonin 5-HT 1B receptor antagonist which was under development for the treatment of major depressive disorder and anxiety disorders. It was being developed by AstraZeneca. The drug reached phase 1 clinical trials prior to the discontinuation of its development. It was discontinued following unexpected neurotoxicity findings in animals.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372016342 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.